Practicalities of Obesity Management for the Cardiologist: A "Quick Start" Companion to the CKM Guidelines.
Pagidipati Neha J NJ
Johnson & Johnson Services, Inc. · 辅助诊断 · 辅助诊断
ibrutinib 是一种辅助诊断,由Johnson & Johnson Services, Inc.研发。该药已获批,用于治疗相关适应症,给药途径:Others。
| 公司 | Johnson & Johnson Services, Inc. |
| 药物类别 | 辅助诊断 |
| 给药途径 | Others |
| 状态 | Approved |
ibrutinib 针对 1 个适应症,涉及 1 个治疗领域。
| 治疗领域 | 疾病/病症 | 分期 |
|---|---|---|
| Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Uterine cancer | ✓ Approved |
Pagidipati Neha J NJ
Habib Ihab I, Mohteshamuddin Khaja K, Mohamed Mohamed-Yousif Ibrahim MI, Bhagya Lakshmi Glindya G et al.
Companion animal shelters represent underexplored settings for One Health antimicrobial resistance (AMR) surveillance. This study investigated the recovery, antimicrobial resistance, and genomic features of Enterococcus spp. from shelter dogs and cats in the United Arab Emirates (UAE). Rectal swabs were collected from 230 shelter animals, including 129 dogs and 101 cats, across five shelters in four UAE emirates/cities. Enterococcus isolates were recovered using selective culture and identified by MALDI-TOF MS. Confirmed Enterococcus faecalis and Enterococcus faecium isolates underwent antimicrobial susceptibility testing using Vitek-2. Multidrug-resistant (MDR) and linezolid-resistant isolates were subjected to whole-genome sequencing (WGS) for multilocus sequence typing, resistome analysis, single-nucleotide polymorphism-based phylogeny, phenotype-genotype concordance assessment, and virulence-associated gene profiling. Enterococcus spp. were recovered from 122/230 animals (53.0%; 95% confidence interval: 46.6-59.4), with higher recovery in dogs (71.3% (92/129)) than cats (29.7% (30/101)). Overall, E. faecalis accounted for 63/122 isolates (51.6%) and E. faecium for 59/122 isolates (48.4%). Phenotypic resistance was most frequent for tetracycline (51.6%), erythromycin (30.3%), ciprofloxacin (27.2%), high-level streptomycin (20.5%), and high-level gentamicin (9.8%). All isolates were susceptible to ampicillin, vancomycin, teicoplanin, and tigecycline. MDR was detected in 25/122 isolates (20.5%) and was more frequent among E. faecalis than E. faecium. Linezolid resistance was detected in two isolates recovered from two dogs, one male and one female, housed in the same shelter. WGS of 25 MDR or linezolid-resistant isolates revealed diverse sequence types, including dominant E. faecalis ST16, shelter-associated SNP clusters, and multiple resistance determinants, including erm(B), tet(L), tet(M), aminoglycoside resistance genes, quinolone resistance-associated mutations, and plasmid-predicted optrA in three E. faecalis isolates. Virulence-associated genes were more prominent in E. faecalis, particularly the endocarditis- and biofilm-associated pilus genes involved in adhesion and biofilm formation, together with a putative exoenzyme-associated factor potentially contributing to host interaction and bacterial fitness. Shelter dogs and cats in the UAE carried E. faecalis and E. faecium with phenotypic AMR, MDR profiles, and diverse genomic resistance determinants. The detection of linezolid resistance and plasmid-predicted optrA supports inclusion of shelter companion animals in regional One Health AMR surveillance.
Khan Samina S, Ashrafinia Narges N, Mathura Pamela P, Puttagunta Lakshmi L et al.
A chart audit (pre-intervention, PRE) of endoscopic ultrasound (EUS)-fine needle biopsy (FNB) of solid masses identified a diagnostic yield of 75%. To improve diagnostic yield, a quality improvement intervention targeting tissue procurement and processing was developed and trialed (post-intervention, POST). Increase needle passes to ≥3/mass, limit the personnel preparing cytology slides, and replace saline with formalin for cell block preparation. A POST chart audit was undertaken for solid mass EUS-FNB from January 2024-December 2024, with quarterly reviews. Only a definite diagnosis was used to calculate diagnostic yield. 241 patients underwent 262 EUS-FNBs. Diagnostic yield was 81% in POST vs. 75% in PRE (p = ns). Single passes decreased to 14% in POST vs. 20% in PRE (p = ns), with similar diagnostic yield (57% vs. 56%, respectively). Number of ≥3 passes increased significantly (47% POST vs. 12% PRE, P < .0001). In POST, 86% of single passes were performed in the first half vs. 14% in the second (P = .012). Only 25% of ≥3 passes were performed in the first half vs. 75% in the second (P = .06). Diagnostic yield improved significantly between the first and second halves (72% vs. 90%, P < .0001). Replacing saline with formalin for cell block improved diagnostic yield (57% vs. 75%, P = .062). Limiting the personnel making slides from 25 nurses (PRE) to 3 endoscopists (POST) had no impact on diagnostic yield. Critical practice assessment, regular audit, and continued reinforcement led to a significant improvement in EUS-FNB diagnostic yield to 90% by increasing the number of needle passes to ≥3/mass.
Mlodziankowska Natalia N, Kampioni Malgorzata M MM, Tomczyk Katarzyna K, Kedzia Witold W WW et al.
Intraoperative frozen section (FS) analysis is widely used during surgery for ovarian tumors to guide the extent of the operative procedure. It plays a particularly significant role in young women, in whom fertility-sparing surgery is considered. Despite its high clinical utility, FS has technical limitations that may result in discrepancies compared with final histopathological diagnosis. To assess the concordance between intraoperative frozen section diagnosis and final histopathological examination of ovarian tumors, and to evaluate the diagnostic accuracy, sensitivity, specificity, and predictive values of FS. The analysis included finally 100 women aged 11-78 years from among 114 who were hospitalized and underwent surgery for ovarian tumors conducted at a tertiary Gynecology and Obstetrics Clinical Hospital from January to June 2025. Frozen section diagnoses were compared with final histopathological results. Concordance rates, patterns of diagnostic discrepancies, and diagnostic performance parameters (sensitivity, specificity, positive predictive value [PPV], and negative predictive value [NPV]) were calculated using final histopathology as the reference standard. Overall concordance between frozen section and final histopathology was 85%. Diagnostic discrepancies were observed in 15% of cases, with only 2% considered clinically significant. Frozen section showed excellent diagnostic performance for benign tumors (sensitivity 100%, specificity 94.1%) and malignant tumors (specificity and PPV 100%). The lowest diagnostic accuracy was observed for borderline tumors, which accounted for most clinically relevant discrepancies. The most frequent source of discordance involved hemorrhagic cysts, which were ultimately diagnosed as endometriotic cysts on final histopathology. Intraoperative frozen section analysis is a reliable and safe diagnostic tool that effectively supports surgical decision-making in ovarian tumors. Its high diagnostic accuracy and predictive values confirm its clinical value, particularly in tailoring the extent of surgery. Special caution is warranted in the interpretation of borderline tumors, for which final histopathological examination remains essential.
Kim Do Hyun DH, Jang David W DW, Hwang Se Hwan SH
Salivary pepsin has been proposed as a non-invasive biomarker for diagnosing laryngopharyngeal reflux (LPR); however, its diagnostic utility remains uncertain due to inconsistent findings across studies. This meta-analysis evaluated the diagnostic accuracy of a rapid lateral flow test (Peptest) compared to the reference standard of multichannel intraluminal impedance-pH (MII-pH) monitoring. Systematic review and meta-analysis of cohort studies. Patients with LPR. The primary outcomes were diagnostic odds ratio (DOR), summary receiver operating characteristic curve and area under the curve (AUC). In total, 11 studies comprising 928 samples were included. The diagnostic performance of salivary pepsin for LPR was analysed at cut-off values of 16, 45-50 and 100 ng/mL. The pooled DOR and AUC were 3.49 and 0.684 at 16 ng/mL, 6.08 and 0.772 at 45-50 ng/mL and 4.78 and 0.717 at 100 ng/mL, respectively. Multiple-time sampling significantly improved sensitivity compared to single-time sampling across all cut-off values (0.82 vs. 0.33-0.63 at 16 ng/mL; p < 0.0001), although specificity was slightly lower. The Peptest demonstrates potential as a simple, non-invasive diagnostic alternative to 24-h-MII-pH monitoring for LPR. Among the evaluated thresholds, a cut-off of 45-50 ng/mL provided the highest diagnostic accuracy. Collecting multiple saliva samples may further enhance detection sensitivity. However, in patients with a high clinical suspicion of LPR but negative Peptest results, 24-h-MII-pH monitoring remains necessary to confirm the diagnosis due to the test's limited negative predictive value.
Mirabelli Flavio Marco FM, Repaci Emma E, Bandelli Gian Piero GP, Galasso Thomas T et al.
Diagnostic work-up of peripheral pulmonary lesions (PPLs) remains a challenge in interventional pulmonology. Conventional bronchoscopy and trans-thoracic needle aspiration (TTNA) often entail limitations in accuracy or safety. Robotic-assisted bronchoscopy with shape-sensing technology (ssRAB) combined with artificial intelligence (AI)-aided augmented fluoroscopy (LungVision system) represents an innovative approach to enhance lesion localization and diagnostic yield for small or otherwise hard-to-reach lesions while maintaining the safety profile of the procedure. This retrospective observational study included all procedures performed under general anesthesia using the ssRAB (Ion™ robotic platform) in combination with C-arm based computed tomography (LungVision System) at the Interventional Pulmonology Unit of IRCCS Azienda Ospedaliero-Universitaria, Policlinico Sant'Orsola, Bologna (Italy), between December 2024 and September 2025. Overall, 82 patients with 94 sampled pulmonary lesions were included; in 12 patients, two distinct nodules were sampled during the same bronchoscopic procedure. Lesions features, procedural characteristics, diagnostic yield and complications were collected and statistically analyzed. Diagnostic yield was defined according to the 2024 Delphi consensus and STARD 2015 guidelines. This study included 82 patients and 94 sampled pulmonary nodules. The median size of the lesion was 14 mm (IQR 11-18 mm). Target lesions were identified by radial endobronchial ultrasound (r-EBUS) in 80% of cases. A definitive cyto-histologic diagnosis was achieved in 74.5% of cases. Lesions ≥10 mm yielded a 79.2% diagnostic rate, versus 59.1% for smaller nodules. Diagnostic success was independently predicted by upper lobe location (OR 3.28; p = 0.031) and lesion visibility on CABT (OR 3.22; p = 0.043). The overall complication rate was 3.3% (three pneumothorax cases; no major bleeding). The median procedure time was 34.5 min, and most procedures were performed in a day-hospital setting. The integration of robotic-assisted bronchoscopy with the LungVision system exhibited high diagnostic efficacy and a strong safety profile when sampling peripheral lung lesions. The synergy of real-time AI aided augmented fluoroscopy and robotic technologies facilitates precise lesion targeting, even within anatomically complex areas. However, follow-up data were not available for non-diagnostic cases; therefore, false-negative rates, sensitivity, and diagnostic accuracy could not be assessed. Given the significant cost associated with this procedure, future prospective studies are warranted to further validate these results and refine patient selection criteria to optimize its clinical application.
注册免费账户还可查看另外 9996 篇文献
免费注册查看全部文献 →